Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: A SPECT study

Psychiatry Research - Neuroimaging

Volumn 123, Issue 2, 2003, Pages 125-134

  Lacerda, Acioly L T ^a,b   Dalgalarrondo, Paulo ^b   Caetano, Dorgival ^b   Camargo, Edwaldo E ^b   Etchebehere, Elba C S C ^b   Soares, Jair C ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Frontal cortex; Functional neuroimaging; Obsessive compulsive disorder; Prefrontal subcortical circuits; Single photon emission computed tomography; Thalamus

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN REGION; BRAZIL; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DISEASE SEVERITY; EDUCATION; FEMALE; GENDER; HANDEDNESS; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS;

EID: 0038015357     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(03)00061-1     Document Type: Article

References (46)

1. Abbruzzese M., Ferri S., Scarone S. The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia. 35:1997;907-912.
2. Alptekin K., Degirmenci B., Kivircik B., Durak H., Yemez B., Derebek E., Tunca Z. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression. Psychiatry Research: Neuroimaging. 107:2002;51-56.
3. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. fourth ed: 1994;American Psychiatric Press, Washington, DC.
4. Annett M. A classification of hand preference by association analysis. British Journal of Psychology. 61:1970;303-321.
5. Asbahr F.R. Rating scales for obsessive compulsive disorder in children and adolescents (Portuguese). Revista de Psiquiatria Clinica. 25:1997;310-319.
6. Baxter L.R. Jr. Neuroimaging studies of obsessive compulsive disorder. Psychiatric Clinics of North America. 15:1992;871-884.
7. Baxter L.R. Jr., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Alazraki A., Selin C.E., Ferng H.K., Munford P., Phelps M.E. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry. 49:1992;681-689.
8. Baxter L.R. Jr., Schwartz J.M., Mazziotta J.C., Phelps M.E., Pahl J.J., Guze B.H., Fairbanks L. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. American Journal of Psychiatry. 145:1988;1560-1563.
9. Bebbington P.E. Epidemiology of obsessive-compulsive disorder. British Journal of Psychiatry. 173:(Suppl. 35):1998;2-6.
10. Behar D., Rapoport J.L., Berg C.J., Denckla M.B., Mann L., Cox C., Fedio P., Zahn T., Wolfman M.G. Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder. American Journal of Psychiatry. 141:1984;363-369.
11. Boone F., Anath J., Philpott L., Kaur A., Djenderedjian A. Neuropsychological characteristics of nondepressed adults with OCD. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 4:1991;96-109.
12. Busatto G.F., Buchpiguel C.A., Zamignani D.R., Garrido G.E., Glabus M.F., Rosario-Campos M.C., Castro C.C., Maia A., Rocha E.T., McGuire P.K., Miguel E.C. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study. Journal of the American Academy of Child and Adolescent Psychiatry. 40:2001;347-354.
13. Busatto G.F., Zamignani D.R., Buchpiguel C.A., Garrido G.E., Glabus M.F., Rocha E.T., Maia A.F., Rosario-Campos M.C., Castro C.C., Furuie S.S., Gutierrez M.A., McGuire P.K., Miguel E.C. A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Research. 99:2000;15-27.
14. Cavedini P., Ferri S., Scarone S., Bellodi L. Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study. Psychiatry Research. 78:1998;21-28.
15. Christensen K.J., Kim S.W., Dysken M.W., Hoover K.M. Neuropsychological performance in obsessive-compulsive disorder. Biological Psychiatry. 31:1992;4-18.
16. Cox C., Fedio P., Rapoport J. Neuropsychological testing of obsessive compulsive adolescents. Rapoport J. OCD in Children and Adolescents. 1989;73-85 American Psychiatric Press, Washington, DC.
17. Devous M.D. Sr., Trivedi M.H., Rush A.J. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. Journal of Nuclear Medicine. 42:2001;535-542.
18. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry. 33:1976;766-771.
19. Galderisi S., Mucci A., Catapano F., D'Amato A.C., Maj M. Neuropsychological slowness in obsessive-compulsive patients. Is it confined to tests involving the fronto-subcortical systems? British Journal of Psychiatry. 167:1995;394-398.
20. Gilbert A.R., Moore G.J., Keshavan M.S., Paulson L.A., Narula V., Mac Master F.P., Stewart C.M., Rosenberg D.R. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Archives of General Psychiatry. 57:2000;449-456.
21. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry. 46:1989;1006-1011.
22. Guy W. E.C.D.E.U. Assessment Manual for Psychopharmacology. 1976;76-338 National Institute for Mental Health, US Department of Health, Education and Welfare, Washington, DC.
23. Hoehn-Saric R., Pearlson G.D., Harris G.J., Machlin S.R., Camargo E.E. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. American Journal of Psychiatry. 148:1991;1243-1245.
24. Hollander E., Prohovnik I., Stein D.J. Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences. 7:1995;485-490.
25. Insel T.R., Donnelly E.F., Lalakea M.L., Alterman I.S., Murphy D.L. Neurological and neuropsychological studies of patients with obsessive-compulsive disorder. Biological Psychiatry. 18:1983;741-751.
26. Insel T.R., Winslow J.T. Neurobiology of obsessive compulsive disorder. Psychiatric Clinics of North America. 15:1992;813-824.
27. Lebrand C., Cases O., Adelbrecht C., Doye A., Alvarez C., El Mestikawy S., Seif I., Gaspar P. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron. 17:1996;823-835.
28. 99mTcHMPAO single photon emission tomography (SPECT). British Journal of Psychiatry. 171:1997;346-350.
29. Machlin S.R., Harris G.J., Pearlson G.D., Hoehn-Saric R., Jeffery P., Camargo E.E. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. American Journal of Psychiatry. 148:1991;1240-1242.
30. McGuire P.K., Bench C.J., Frith C.D., Marks I.M., Frackowiak R.S., Dolan R.J. Functional anatomy of obsessive-compulsive phenomena. British Journal of Psychiatry. 164:1994;459-468.
31. Miller D.D., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biological Psychiatry. 49:2001;704-715.
32. Modell J.G., Mountz J.M., Curtis G.C., Greden J.F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences. 1:1989;27-36.
33. Nelson E., Early T.S., Haller J.W. Visual attention in obsessive-compulsive disorder. Psychiatry Research. 49:1993;183-196.
34. Okasha A., Rafaat M., Mahallawy N., El Nahas G., El Dawla A.S., Sayed M., El Kholi S. Cognitive dysfunction in obsessive-compulsive disorder. Acta Psychiatrica Scandinavica. 101:2000;281-285.
35. 18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. British Journal of Psychiatry. 166:1995;244-250.
36. Rapoport J.L. The neurobiology of obsessive-compulsive disorder. Journal of the American Medical Association. 260:1988;2888-2890.
37. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Archives of General Psychiatry. 51:1994;62-70.
38. Reinsel R.A., Veselis R.A., Dnistrian A.M., Feshchenko V.A., Beattie B.J., Duff M.R. Midazolam decreases cerebral blood flow in the left prefrontal cortex in a dose-dependent fashion. International Journal of Neuropsychopharmacology. 3:2000;117-127.
39. 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biological Psychiatry. 38:1995;429-437.
40. Rubin R.T., Villanueva-Meyer J., Ananth J., Trajmar P.G., Mena I. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography. Archives of General Psychiatry. 49:1992;695-702.
41. Saxena S., Brody A.L., Maidment K.M., Dunkin J.J., Colgan M., Alborzian S., Phelps M.E., Baxter L.R. Jr. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology. 21:1999;683-693.
42. Saxena S., Brody A.L., Schwartz J.M., Baxter L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. British Journal of Psychiatry. (Suppl. 35):1998;26-37.
43. Stein D.J., Van Heerden B., Wessels C.J., Van Kradenburg J., Warwick J., Wasserman H.J. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor. Progress in Neuro-psychopharmacology and Biological Psychiatry. 23:1999;1079-1099.
44. Swedo S.E., Schapiro M.B., Grady C.L., Cheslow D.L., Leonard H.L., Kumar A., Friedland R., Rapoport S.I., Rapoport J.L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Archives of General Psychiatry. 46:1989;518-523.
45. Van der Werf Y.D., Witter M.P., Uylings H.B., Jolles J. Neuropsychology of infarctions in the thalamus: a review. Neuropsychologia. 38:2000;613-627.
46. Zohar J., Insel T.R., Berman K.F., Foa E.B., Hill J.L., Weinberger D.R. Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. Archives of General Psychiatry. 46:1989;505-510.